After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
KYMR belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Kymera Therapeutics Inc is $4.31B. A total of 0.77 million shares were traded on the day, compared to an average of 750.68K shares.
In the most recent transaction, Mainolfi Nello sold 30,000 shares of KYMR for 60.99 per share on Oct 29 ’25. After the transaction, the Chief Executive Officer now owns 660,482 company shares. In a previous transaction on Oct 29 ’25, Mainolfi Nello bought 30,000 shares at 61.68 per share.
Among the insiders who sold shares, Gollob Jared disposed of 59,576 shares on Oct 15 ’25 at a per-share price of $61.42. This resulted in the Chief Medical Officer holding 109,992 shares of KYMR after the transaction. In another insider transaction, Jared Gollob bought 59,576 shares at $58.26 per share on Oct 15 ’25.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, KYMR has a high of $63.96 and a low of $19.44.
As of this writing, KYMR has an earnings estimate of -$0.86 per share for the current quarter. EPS was calculated based on a consensus of 21.0 estimates, with a high estimate of -$0.35 per share and a lower estimate of -$1.21. The company reported an EPS of -$0.89 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. KYMR’s latest balance sheet shows that the firm has $442.42M in Cash & Short Term Investments as of fiscal 2021. There were $17.96M in debt and $92.54M in liabilities at the time. Its Book Value Per Share was $13.19, while its Total Shareholder’s Equity was $459.64M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for KYMR is Buy with a score of 4.88.
